EUVIMEDEUVIMED entdecken
Crossref

Assessment of orthodontic treatment needs in patients with β-thalassemia major and sickle cell disease

Salmeh Kalbassi, Mohammadreza Younesi, Samira Louni Aligoudarzi

Journal of Clinical Pediatric Dentistry · 2023

DOI: 10.22514/jocpd.2023.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pediatric Dentistry, 2023. Verfasst von Salmeh Kalbassi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Specialist in Orthodontics and Dentofacial Orthopedics, Private clinic in Iran (Tehran, Isfahan), UAE (Dubai) and Oman (Muscat). Hauptthemen laut MEDLINE: beta-Thalassemia, Malocclusion, Malocclusion, Angle Class II, Malocclusion, Angle Class I.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients suffering from hemoglobinopathies may suffer from pathogic dental and orofacial features. This study aimed to assess the prevalence of malocclusion and the need for orthodontic treatment in patients with β-thalassemia major (BTM) and sickle cell disease (SCD). The study was conducted on 311 blood transfusion-dependent patients with BTM or SCD and 400 healthy individuals aged 10 to 16. The types of malocclusion were evaluated based on Angle’s classification and Dewey’s modification, and their oral habits were recorded using a questionnaire. The need for orthodontic treatment was assessed through the Dental Health Component of the Index of Orthodontic Treatment Need (IOTN), and the data were compared with normal participants. The Index of Orthodontic Treatment Need-Dental Health Component (IOTN-DHC) assessment showed that patients had a higher prevalence of objective need for treatment (IOTN grades 4 and 5) compared to healthy children. The prevalence of class II malocclusion was significantly higher in patients. Patients showed significantly less Angle’s Class I malocclusion compared to normal participants. Oral habits were presented in 61%, 64.15% and 62.4% of normal participants, BTM and SCD patients, respectively. The higher prevalence of Angle’s class II malocclusion and higher percentage of IOTN grade 4 and 5 among BTM and SCD patients reveal the importance of early orthodontic assessment and intervention in children with BMT and SDC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaMalocclusionMalocclusion, Angle Class IIMalocclusion, Angle Class IAnemia, Sickle CellChildHumansIndex of Orthodontic Treatment NeedOrthodontics, Corrective

Stichwörter der Autor:innen

Beta thalassemia majorOrthodontic treatment needSickle cell disease

Autor:innen und Institutionen

  • Specialist in Orthodontics and Dentofacial Orthopedics, Private clinic in Iran (Tehran, Isfahan), UAE (Dubai) and Oman (Muscat).
  • Department of hematology, Tehran university of medical sciences, 1416634793 Tehran, Iran.
  • Department of hematology, Amiralmomenin diagnostic laboratory, 1563479524 Tehran, Iran.

Zitieren

APA

Kalbassi, S., Younesi, M., & Aligoudarzi, S. L. (2023). Assessment of orthodontic treatment needs in patients with β-thalassemia major and sickle cell disease. Journal of Clinical Pediatric Dentistry. https://doi.org/10.22514/jocpd.2023.006

Vancouver

Kalbassi S, Younesi M, Aligoudarzi SL. Assessment of orthodontic treatment needs in patients with β-thalassemia major and sickle cell disease. Journal of Clinical Pediatric Dentistry. 2023. doi:10.22514/jocpd.2023.006

BibTeX
@article{Kalbassi2023,
  author = {Kalbassi, Salmeh and Younesi, Mohammadreza and Aligoudarzi, Samira Louni},
  title = {Assessment of orthodontic treatment needs in patients with β-thalassemia major and sickle cell disease},
  journal = {Journal of Clinical Pediatric Dentistry},
  year = {2023},
  doi = {10.22514/jocpd.2023.006}
}
Kostenlos starten →